Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

1(25.0%)

Phase 1

1(25.0%)

4Total

N/A(2)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04749888Not ApplicableActive Not Recruiting

Impact of the Korea Early Childhood Home-visiting Intervention

Role: collaborator

NCT03822156Completed

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Role: lead

NCT03814837Unknown

A Study for the Ocular Toxocariasis Patients With the Pulmonary Toxocariasis, and Ocular Toxocariasis Cohort

Role: lead

NCT02308891Not ApplicableCompleted

A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis

Role: collaborator

NCT01841515Phase 1Completed

Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug

Role: lead

NCT01665781Phase 4Completed

Erythropoietin in the Prevention of Acute Mountain Sickness

Role: lead

NCT01784458Completed

Clinical Significance of Intra-abdominal Hypertension in Surgical Patients With Severe Sepsis

Role: lead

All 7 trials loaded